Nephrocare Health Services Ltd. IPO

We offer comprehensive dialysis care through our network of clinics – from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. We are India’s largest dialysis service provider in terms of number of patients served, ... clinics, cities covered, treatments performed, revenue, and EBITDA (excluding other income) in Fiscal 2025. (Source: F&S Report) In Fiscal 2025, we served 29,281 patients and completed 2,885,450 treatments in India which represented approximately 10% of the total dialysis patients in India. We have a global network of 519 clinics and are the most widely distributed dialysis network in India with an extensive pan-India network of clinics across 288 cities, as of September 30, 2025 (Source: F&S Report) and 21 States and four Union Territories. In the six months period ended September 30, 2025 and Fiscal 2025, 2024, and 2023, our revenue from operations was ? 4,735.01 million, ? 7,558.12 million, ? 5,661.55 million and ? 4,372.95 million, respectively, highest amongst major organized dialysis service chains in India (Source: F&S Report). Our Profit / (loss) for the period/ year was ? 142.28 million, ? 670.96 million, ? 351.33 million and ? (117.89) million in the six months period ended September 30, 2025, Fiscals 2025, 2024 and 2023, respectively. Our EBITDA (excluding other income) has consistently increased and was ? 1,103.10 million, ? 1,666.37 million, ? 996.58 million and ? 485.95 million in the six months period ended September 30, 2025, Fiscals 2025, 2024 and 2023, respectively. We are 4.4 times the size of the next largest organized dialysis provider in India in terms of operating revenue in Fiscal 2024. (Source: F&S Report) We are also the largest dialysis service provider in Asia in 2025 and the fifth largest globally based on the number of treatments performed in Fiscal 2025.(Source: F&S Report) Read more

Our Company was incorporated as “Nephrocare Health Services Private Limited”, a private limited company under the Companies Act, 1956, at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh (“RoC Andhra Pradesh”) on ... December 18, 2009. Pursuant to resolutions dated April 11, 2025 and June 2, 2025 passed by our Board and Shareholders, respectively, our Company was converted into a public limited company and consequently, the name of our Company was changed to “Nephrocare Health Services Limited” with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.

The global revenue from dialysis services was estimated to be around USD 75.20 billion in 2024 and it is estimated to grow at a CAGR of 7.1% during the forecast period (2024 to 2029) to reach around USD 106.2 billion by 2029 driven by factors such as increasing prevalence of CKD, improved ... diagnosis of ESRD and increasing access to dialysis service. The total number of dialysis patients is expected to increase from 0.28 million in 2024 to 0.52 million by 2029, growing at a CAGR of 12.7%. (Source: F&S Report) Read more